Azathioprine
Azathioprine is a mercaptopurine derivative which has cytotoxic and immunosuppressive effects.
The main uses of azathioprine include:
- the treatment of leukaemia
- to prevent rejection of transplanted organs
- in the treatment of active progressive rheumatoid arthritis
Azathioprine is metabolised to mercaptopurine and then to thioinosinate which interferes with purine metabolism.
Mercaptopurine interacts with allopurinol. The dose of azathioprine should be reduced if allopurinol is prescribed simultaneously.
The most common side-effects of azathioprine are myelosuppression and hepatotoxicity.
The summary of product characteristics should be consulted before prescribing this drug.
Related pages
- Azathioprine in rheumatoid arthritis
- Azathioprine in multiple sclerosis
- Azathioprine in myasthenia gravis
- Azathioprine in Crohn's disease and ulcerative colitis
- Side effects of azathioprine
- Interactions
- Contra-indications and warnings for azathioprine
- Azathioprine during pregnancy
- Thiopurine S-methyl transferase (TPMT)
- Monitoring azathioprine
- NUDT15 deficiency and thiopurine toxicity
Create an account to add page annotations
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page